|
USA-NH-RAYMOND ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- China’s Biotech Advances Threaten U. S. Dominance, Warns . . .
Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U S , while barring companies from
- China is beating U. S. in biotech advances, report warns - Axios
The U S slipping as the world's biotechnology leader "would signal a global power shift toward China," says the report from the congressionally appointed National Security Commission on Emerging Biotechnology
- Executive Summary - Biotech
2 5b Congress must prohibit companies that work with U S national security agencies and the Department of Health and Human Services from using certain Chinese biotechnology suppliers that are deemed to pose a national security threat
- US commission urges action to keep biotech advantage over China
A U S congressional commission has made the case for “swift action” to maintain the nation’s role as a biotech superpower, while warning the sector is “dangerously close to falling behind
- US risks losing biotech edge to China, report warns
The U S risks losing a once-decisive edge over China in biotechnology unless the federal government prioritizes the sector’s advancement with new funding and policies, a bipartisan commission warned in a report issued Tuesday
- Amid Trade Tensions, Commission Warns China is . . . - BioSpace
A congressional commission is sounding the alarm on the US biotech industry, raising concerns that China could soon become the world’s leader in terms of innovation In a report released Tuesday, the National Security Commission on Emerging Biotechnology (NSCEB) found that over the last two decade, “the U S government’s approach [in
- US government must spend $15B to counter China’s biotech . . .
With China aggressively pursuing a strategy to become the world’s biotechnology leader, the U S government must invest a minimum of $15 billion over the next five years in the sector to maintain global dominance That’s the finding of a final report to Congress from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB)
|
|